IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 84 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $364,000 | +12.0% | 40,815 | -83.4% | 0.04% | +2.9% |
Q2 2018 | $325,000 | -28.4% | 246,527 | 0.0% | 0.03% | -33.3% |
Q1 2018 | $454,000 | -12.7% | 246,527 | 0.0% | 0.05% | -8.9% |
Q4 2017 | $520,000 | -5.5% | 246,527 | 0.0% | 0.06% | -9.7% |
Q3 2017 | $550,000 | +29.7% | 246,527 | 0.0% | 0.06% | +24.0% |
Q2 2017 | $424,000 | -30.4% | 246,527 | 0.0% | 0.05% | -33.3% |
Q1 2017 | $609,000 | +64.6% | 246,527 | 0.0% | 0.08% | +50.0% |
Q4 2016 | $370,000 | -41.4% | 246,527 | 0.0% | 0.05% | -51.9% |
Q3 2016 | $631,000 | +67.4% | 246,527 | 0.0% | 0.10% | +60.0% |
Q2 2016 | $377,000 | -22.7% | 246,527 | 0.0% | 0.06% | -25.3% |
Q1 2016 | $488,000 | -21.0% | 246,527 | +23.3% | 0.09% | -20.9% |
Q4 2015 | $618,000 | -7.8% | 200,000 | 0.0% | 0.11% | -19.7% |
Q3 2015 | $670,000 | -9.7% | 200,000 | 0.0% | 0.14% | -4.9% |
Q2 2015 | $742,000 | 0.0% | 200,000 | 0.0% | 0.14% | -4.6% |
Q1 2015 | $742,000 | -15.9% | 200,000 | 0.0% | 0.15% | -18.8% |
Q4 2014 | $882,000 | – | 200,000 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 4,525,000 | $7,874,000 | 1.40% |
DAFNA Capital Management LLC | 200,000 | $348,000 | 0.38% |
HealthCor Management, L.P. | 3,270,000 | $5,690,000 | 0.30% |
Baker Brothers Advisors | 5,865,000 | $10,205,000 | 0.14% |
Spark Investment Management LLC | 152,500 | $262,000 | 0.06% |
NATIXIS | 3,148,916 | $5,479,000 | 0.06% |
GUARDIAN LIFE INSURANCE CO OF AMERICA | 371,759 | $647,000 | 0.05% |
LEAVELL INVESTMENT MANAGEMENT, INC. | 81,271 | $141,000 | 0.02% |
TFS CAPITAL LLC | 118,232 | $206,000 | 0.01% |
First Eagle Investment Management, LLC | 1,434,296 | $2,496,000 | 0.01% |